Non-Interventional Study to Review the Changes of Depression after First-Year of Tofacitinib Treatment in Rheumatoid Arthritis (XELJANZ®)First published 01/04/2021 Last updated 22/05/2024 EU PAS number: EUPAS40263StudyOngoing